Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Search Site

Over 2,750 Pages of
Hepatitis C Info, Here:
Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
1 Department of Epidemiology, Second Military Medical University, Shanghai, China 2 Department of Acute Infectious Diseases, Center for Disease Control and Prevention, Shanghai, China 3 Department of Infectious Diseases, The 1st Affiliated Hospital,

Hepatitis C virus entry: possible targets for therapy
Institute for Biomedical Research, University of Birmingham, Birmingham, UK Correspondence to: Professor J A McKeating, Institute for Biomedical Research, The Medical School, Vincent Drive, Birmingham B15 2TT, UK; j.a.mckeating@bham.ac.uk The first 150

Hepatitis A outbreak spreads at Consolidated School
Other cases possible Today's most viewed articles Was it really 'obvious' McKey would win ?America?s Next Top Model?? - 11/19/2008 Police: Second worker stole thousands from York business - 11/19/2008 Hugh Jackman robs Christian Bale of 'Sexiest

UPDATES AND COMMENTARY RSS Feed

Who Will Respond to Hepatitis C Treatment
The relatively new field of proteomics may be able to predict who will respond to Hepatitis C therapy - before treatment even begins....

Antivirals Combined Without Interferon: New Trial
Three companies unite to begin an innovative Hepatitis C trial, where two oral antiviral drugs will be combined in the absence of interferon....

HCV May Be Able to Be Cleared from Both Blood and Liver
Viral clearance doubled in a Hepatitis C Phase II trial during standard therapy when coupled with GlobeImmune's GI-5005. Because Hepatitis C must be eradicated not just from the blood, but also the liver, GI-5005's ability to speed the clearance rate...
Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis: A Randomized Multicenter Trial

Fig. 3. Cumulative proportion (Kaplan-Meier plot) of patients surviving.

Return To Article

table Of Contents
  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 20 Nov 2008